Characteristic | No. (%) |
---|---|
Sex | |
 Male | 118 (83) |
 Female | 24 (17) |
AGE | |
 Median | 49.6 |
 Range | 15–71 |
  ≤ 45 | 73 (51) |
 > 45 | 69 (49) |
 Follow-up Time | |
 Median (range) | 73 (13–125) |
Tumor Size | |
 T1 + T2 | 27 (19) |
 T3 + T4 | 115 (81) |
Lymphoid nodal states | |
 N0-1 | 76 (53) |
 N2-3 | 66 (47) |
Clinical Stage | |
 1 + 2 | 15 (11) |
 3 + 4 | 127 (89) |
Local-regional relapse | |
 Yes | 16 (11) |
 No | 126 (89) |
Metastasis | |
 Yes | 4 (3) |
 No | 138 (97) |
WHO histological classification | |
 NKUC | 131 (92) |
 NKDC | 11 (8) |
OS rate (%) | |
 5-year | 78.2% |